VX-210
VX15-210-101
Phase 3 small_molecule terminated
Quick answer
VX-210 for Cervical Spinal Cord Injury is a Phase 3 program (small_molecule) at Vertex Pharmaceuticals (Ireland) Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Vertex Pharmaceuticals (Ireland) Limited
- Indication
- Cervical Spinal Cord Injury
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- terminated